Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/1998
06/16/1998US5766585 Infecting bone marrow cells with recombinant retroviral expression vector that contains a polynucleotide sequence coding a biologically active interleukin receptor antagonist protein, injecting into host; antiinflammatory agents
06/16/1998US5766582 Storage stability; mixture with buffer, stabilizer and chelate compound
06/16/1998US5766581 Increasing platelet number with polypeptide molecules attached to polyethylene glycol
06/16/1998US5766570 Lymphocyte activation antigens and antibodies thereto
06/16/1998US5766520 Preservation by foam formation
06/16/1998US5765538 Pump device for a fuel vapor retention system of an internal combustion engine
06/13/1998CA2224025A1 Novel antibiotic, feglymycin, processes for its preparation and its use
06/12/1998CA2192754A1 Nur-re a response element which binds dimers of nur nuclear receptors and method of use therefor
06/11/1998WO1998025142A1 Alarm related peptides and nucleic acids and diagnosis using them
06/11/1998WO1998024927A1 Compositions and methods for administering pneumococcal dna
06/11/1998WO1998024925A1 Tissue specific and target rna-specific ribozymes as antimicrobial therapeutics against microbial pathogens
06/11/1998WO1998024924A1 Genetic modification of primate hemopoietic repopulating stem cells
06/11/1998WO1998024923A1 Inactivation of hiv co-receptors as therapy for hiv infection
06/11/1998WO1998024922A1 Insulin-like growth factor i (igf-i) expression system and methods of use
06/11/1998WO1998024916A1 Novel calpaines, production and use thereof
06/11/1998WO1998024915A1 Protein phosphatase 2a subunit polypeptide
06/11/1998WO1998024914A1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy
06/11/1998WO1998024913A2 Method and reagent for the treatment of a disease associated with interleukin-2 receptor gamma-chain expression
06/11/1998WO1998024911A2 Mutants of streptococcal toxin a and methods of use
06/11/1998WO1998024910A2 Mutants of streptococcal toxin c and methods of use
06/11/1998WO1998024909A1 Chaperone fragments
06/11/1998WO1998024908A1 Human chemokine beta-13
06/11/1998WO1998024905A2 Secreted proteins and polynucleotides encoding them
06/11/1998WO1998024904A2 Il-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders
06/11/1998WO1998024903A1 Isolation and use of erythroid differentiation and denucleation factors
06/11/1998WO1998024901A1 Lung growth factor variant
06/11/1998WO1998024900A1 Human g-protein receptor hcegh45, a pacap-like (g-protein pituitary adenylate cyclase activating polypeptide-like) receptor
06/11/1998WO1998024898A2 Therapeutic composition comprising the kal protein and use of the kal protein
06/11/1998WO1998024897A1 Junctional adhesion molecule (jam), a transmembrane protein of tight junctions
06/11/1998WO1998024896A2 Muteins of obese protein
06/11/1998WO1998024892A1 Ve-cadherin promoter and its uses
06/11/1998WO1998024888A2 Polypeptides encoded by a human lipase-like gene, compositions and methods
06/11/1998WO1998024887A2 Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof
06/11/1998WO1998024884A1 Transgenic non-human animals capable of producing heterologous antibodies
06/11/1998WO1998024817A1 Novel dna, novel protein, and novel antibody
06/11/1998WO1998024814A2 N-terminally modified polypeptide enzyme inhibitors, and related therapeutic methods and pharmaceutical compositions
06/11/1998WO1998024813A2 Keratinocyte growth factors and their use in combination with glucagon-like peptide derivatives
06/11/1998WO1998024812A2 A6la5a12 polypeptides and polynucleotides and methods of use therefor
06/11/1998WO1998024811A2 Vascular endothelial growth factor
06/11/1998WO1998024810A2 Vertebrate homologues of unc-53 protein of c. elegans
06/11/1998WO1998024809A1 Peptides agonists of bradykinine b2 receptor
06/11/1998WO1998024808A2 INHIBITION OF IgE-MEDIATED ALLERGIES BY A HUMAN IgE-DERIVED OLIGOPEPTIDE
06/11/1998WO1998024807A2 Somatostatin antagonists
06/11/1998WO1998024806A2 Substituted oxadiazole, thiadiazole and triazole serine protease inhibitors
06/11/1998WO1998024805A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
06/11/1998WO1998024804A2 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
06/11/1998WO1998024797A1 Antisense inhibition of human adhesion molecules
06/11/1998WO1998024485A1 Inactivation of viruses by incubation with caprylate
06/11/1998WO1998024482A2 Use of endothelin conjugates in therapy, new endothelin conjugates, substances containing them, and processes for producing them
06/11/1998WO1998024479A1 Adeno-associated viral vector-mediated delivery of dna to cells of the liver
06/11/1998WO1998024478A2 Tumour therapy
06/11/1998WO1998024477A1 Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases
06/11/1998WO1998024474A1 Inhibition of invasive remodelling
06/11/1998WO1998024472A1 Uses of thioredoxin
06/11/1998WO1998024471A1 Treatment of bone fracture
06/11/1998WO1998024470A1 Topical preparation for introducing peptidaceous pharmacons in living organisms
06/11/1998WO1998024469A1 Il-10 and tgf-beta for treating autoimmune disease
06/11/1998WO1998024468A1 TGFα FOR THE TREATMENT OF OCULAR HYPERTENSION AND GLAUCOMA
06/11/1998WO1998024467A1 Remedies for fulminant hepatitis
06/11/1998WO1998024466A1 THE USE OF INHIBITORS OF TGF-β'S FUNCTIONS TO AMELIORATE OCULAR PATHOLOGY
06/11/1998WO1998024465A1 Wound healing and treatment of fibrosis
06/11/1998WO1998024464A1 Specific antagonists for glucose-dependent insulinotropic polypeptide (gip)
06/11/1998WO1998024463A2 Combination therapy using a tnf binding protein for treating tnf-mediated diseases
06/11/1998WO1998024462A1 USE OF α-CONOTOXIN MII TO TREAT DISORDERS RESULTING FROM NICOTINE-STIMULATED DOPAMINE RELEASE
06/11/1998WO1998024461A1 Peptide synthesis with sulfonyl protecting groups
06/11/1998WO1998024454A1 Human trophoblast and choriocarcinoma inhibition
06/11/1998WO1998024451A1 Uses of oxandrolone
06/11/1998WO1998024417A1 Endotoxin binding to lipid immobilized hemoglobin
06/11/1998WO1998017319A3 Platelet substitutes and conjugation methods suitable for their preparation
06/11/1998WO1998012910A3 Novel CREBa isoform
06/11/1998WO1998011246A3 ENDO-β-GALACTOSIDASE
06/11/1998WO1998006749A3 Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor
06/11/1998WO1998002461A3 Liquid phase peptide syntheses of kl-4 pulmonary surfactant
06/11/1998CA2689842A1 Il-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders
06/11/1998CA2277580A1 Human chemokine beta-13
06/11/1998CA2274316A1 Therapeutic composition comprising the kal protein and use of the kal protein for the treatment of retinal, renal, neuronal and neural injury
06/11/1998CA2274309A1 Novel dna, novel protein, and novel antibody
06/11/1998CA2274304A1 Novel calpaines, production and use thereof
06/11/1998CA2274250A1 Inhibitors of interleukin-1.beta. converting enzyme
06/11/1998CA2274249A1 Inhibitors of interleukin-1.beta. converting enzyme
06/11/1998CA2274105A1 Transgenic non-human animals capable of producing heterologous antibodies
06/11/1998CA2274095A1 Compositions and methods for administering pneumococcal dna
06/11/1998CA2274011A1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy
06/11/1998CA2274002A1 Wound healing and treatment of fibrosis
06/11/1998CA2273924A1 Inactivation of viruses by incubation with caprylate
06/11/1998CA2273857A1 Peptide synthesis with sulfonyl protecting groups
06/11/1998CA2273850A1 Combination therapy using a tnf binding protein for treating tnf-mediated diseases
06/11/1998CA2273845A1 Secreted proteins and polynucleotides encoding them
06/11/1998CA2273843A1 Treatment of bone fracture
06/11/1998CA2273827A1 Vertebrate homologues of unc-53 protein of c. elegans
06/11/1998CA2273822A1 Mutants of streptococcal toxin a and methods of use
06/11/1998CA2273218A1 Tumour therapy
06/11/1998CA2273203A1 Antisense inhibition of human adhesion molecules
06/11/1998CA2273202A1 Junctional adhesion molecule (jam), a transmembrane protein of tight junctions
06/11/1998CA2273198A1 Human g-protein receptor hcegh45, a pacap-like (g-protein pituitary adenylate cyclase activating polypeptide-like) receptor
06/11/1998CA2273192A1 Inactivation of hiv co-receptors as therapy for hiv infection
06/11/1998CA2273190A1 Peptides agonists of bradykinine b2 receptor
06/11/1998CA2273184A1 Alarm related peptides and nucleic acids and diagnosis using them
06/11/1998CA2272994A1 Ve-cadherin promoter and its uses
06/11/1998CA2272848A1 Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof
1 ... 2617 2618 2619 2620 2621 2622 2623 2624 2625 2626 2627 2628 2629 2630 2631 2632 2633 2634 2635 2636 2637 ... 3163